Hence then, the article about promising results from the phase 2 study of novel extended release ketamine tablets r 107 for treatment resistant depression accepted for publication by nature medicine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Promising results from the Phase 2 study of novel extended-release ketamine tablets (R-107) for Treatment-Resistant Depression accepted for publication by Nature Medicine )
Also on site :
- Rooster Runs Wild: Director Zach Braff Breaks Down Greg's Night Out In Episode 4 — And Working With John C. McGinley Across Two Shows
- Meet the ex-Google CMO who quit with a seven-figure package by 28—he says getting promoted was easy because he just ‘disregarded all the rules’
- Marco Bezzecchi wins USA MotoGP to extend perfect start to season